- Home
- SRBK vs PSNL Comparison
SRBK vs PSNL Comparison
Compare SRBK & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$8.55
Company Overview
Basic Information| Metric | SRBK | PSNL |
|---|---|---|
| Founded | 1887 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.0M | 872.1M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | SRBK | PSNL |
|---|---|---|
| Price | $16.91 | $8.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $10.71 |
| AVG Volume (30 Days) | 35.3K | ★ 1.5M |
| Earning Date | 01-30-2026 | 11-04-2025 |
| Dividend Yield | ★ 1.21% | N/A |
| EPS Growth | ★ 374.69 | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | $31,130,000.00 | ★ $69,103,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $20.33 |
| P/E Ratio | $30.90 | ★ N/A |
| Revenue Growth | ★ 0.85 | N/A |
| 52 Week Low | $11.36 | $2.83 |
| 52 Week High | $17.11 | $11.40 |
Technical Indicators
Market Signals| Indicator | SRBK | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 72.03 | 46.75 |
| Support Level | $16.50 | $7.68 |
| Resistance Level | $17.11 | $9.85 |
| Average True Range (ATR) | 0.44 | 0.59 |
| MACD | 0.05 | -0.23 |
| Stochastic Oscillator | 86.85 | 30.67 |
Price Performance
Historical Comparison SRBK
PSNL
About SRBK SR Bancorp Inc.
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.